Larvol Veri

BIOMARKER:

EGFR exon 18 mutation

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

EGFR exon 18 mutation EGFR exon 18 mutation	Non Small Cell Lung Cancer NSCLC	bevacizumab + erlotinib Sensitive: C3 – Early Trials bevacizumab + erlotinib Sensitive : C3
EGFR exon 18 mutation EGFR exon 18 mutation	Non Small Cell Lung Cancer NSCLC	neratinib Sensitive: C3 – Early Trials neratinib Sensitive : C3
EGFR exon 18 mutation EGFR exon 18 mutation	Lung Adenocarcinoma LUAD	bevacizumab + afatinib Sensitive: C4 – Case Studies bevacizumab + afatinib Sensitive : C4